Eam Investors, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$29.79 - $42.29 $1.66 Million - $2.36 Million	-55,842 Reduced 44.78%	68,855 $2.4 Million
Q1 2022 May 13, 2022	BUY	$22.96 - $36.45 $2.86 Million - $4.55 Million	124,697 New	124,697 $4.48 Million
Q1 2019 May 13, 2019	SELL	$19.46 - $25.28 $2.38 Million - $3.09 Million	-122,250 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$17.72 - $22.51 $2.17 Million - $2.75 Million	122,250 New	122,250 $2.43 Million

282

35.4M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.56B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.